findmyKOL
Clinical trialNCT07070219RecruitingPhase 1, PHASE2Interventional

A Study of CTD402 in T-ALL/LBL Patients

SponsorBIOHENG THERAPEUTICS US LLCEnrollment54Acute Lymphocytic Leukemia RefractoryLymphoma, Lymphoblastic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Palo Alto, California, United States

    Recruiting
  • Colorado Blood Cancer Institute

    Denver, Colorado, United States

    Not, yet, recruiting
  • University of Chicago

    Chicago, Illinois, United States

    Not, yet, recruiting
  • Mayo Clinic - Rochester

    Rochester, Minnesota, United States

    Not, yet, recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Recruiting
  • Montefiore Einstein Comprehensive Cancer Center

    The Bronx, New York, United States

    Recruiting
  • Sarah Cannon Research Insitute

    Nashville, Tennessee, United States

    Recruiting
  • Md Anderson Cancer Center

    Houston, Texas, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Oct 2025
Primary completion
30 Sept 2028
Completion
30 Dec 2028
Last update posted
5 Feb 2026
Registered enrollment
54
Registry id
NCT07070219

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.